Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin

Circulation

Volumn 100, Issue 8, 1999, Pages 793-798

  Ikonomidis, Ignatios ^a   Andreotti, Felicita ^a   Economou, Emanouel ^a,b   Stefanadis, Christodoulos ^a,b   Toutouzas, Pavlos ^a,b   Nihoyannopoulos, Petros ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b Ippokration Hospital Thessaloniki   (Greece)

Author keywords

Aspirin; Atherosclerosis; Coronary disease; Interleukins; Ischemia

Indexed keywords

ACETYLSALICYLIC ACID; C REACTIVE PROTEIN; COLONY STIMULATING FACTOR 1; CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 6;

ADULT; AGED; ANGINA PECTORIS; ANTICOAGULATION; ARTICLE; ATHEROSCLEROSIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; EXERCISE; FEMALE; HEART MUSCLE ISCHEMIA; HOLTER MONITORING; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0033600543     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.100.8.793     Document Type: Article

References (46)

1. Liao F, Andalibi A, Lusis AJ, Fogelman AM. Genetic control of the inflammatory response induced by oxidized lipids. Am J Cardiol. 1995; 75:65B-66B.
2. Rajavashisth TB, Andalibi A, Territo MC, Navab M, Fogelman AM, Lusis AJ. Induction of endothelial cell expression of granulocyte and macrophage colony stimulating factors by modified low density lipoproteins. Nature. 1990;344:254-257.
3. Roth P, Stanley ER. The biology of CSF-1 and its receptor. Cur Top Microbiol Immunol. 1992;181:141-167.
4. Dinarello CA, Wolff S. The role of interleukin-1 in disease. N Engl J Med. 1993;328:106-112.
5. Dinarello CA. Interleukin 1 and interleukin 1 antagonism. Blood. 1991; 77:1627-1652.
6. Libby P, Ross R. Cytokines and growth regulatory molacules in atherosclerosis. In: Fuster V, Ross R, Topol EJ, eds. Atherosclerosis and Coronary Artery Disease. Philadelphia: Lippincott Raven; 1996: 585-592.
7. Shyy J, Wickham LL, Hagan JP, Hsieh H, Hu Y, Telian S, Valente AJ, Sung KLP, Chien S. Human monocyte colony-stimulating factor stimulates gene expression of monocyte chemotactic protein 1 and increases the adhesion of monocytes to endothelial monolayers. J Clin Invest. 1993;92:1745-1751.
8. Clinton SK, Underwood R, Hayes L, Sherman LM, Kufe DW, Libby P. Macrophage colony-stimulating factor gene expression in vascular cells and human atherosclerosis. Am J Pathol. 1992;140:301-306.
9. Rosenfeld M, Yla-Herttuala S, Lipton BA, Ord VA, Wittzum JL, Steinberg D. Macrophage colony stimulating factor mRNA and protein in atherosclerotic lesion of rabbits and humans. Am J Pathol. 1992;140: 291-300.
10. Ishibashi S, Inaba T, Shimano H, Harda K, Inoue I, Mokuno H, Mori N, Gotoda T, Takaku F, Yamada N. Monocyte colony stimulating factor enhances cholesterol uptake and degradation of actylated low denstiy lipoproteins and cholesterol esterification in human monocyte derived macrophages. J Biol Chem. 1990;265:14109-14117.
11. Huh HY, Pearce SF, Yesner LM, Schindler JL, Silverstein RL. Regulated expression of CD36 during monocyte to macrophage differentiation: potential role of CD36 in foam cell formation. Blood. 1996;87: 2020-2028.
12. Munn DH, Beall AC, Song D, Wrenn RW, Throckmorton DC. Activation-induced apoptosis in human macrophages: developmental regulation of a novel cell death pathway by macrophage colony stimulating factor and interferon g. J Exp Med. 1995;18:127-136.
13. Sironi M, Brevario F, Prosperio A, Biondi A, Vecchi A, Van Damme L, Dejana E, Mantovani A. IL-1 stimulates IL-6 production in endothelial cells. J Immunol. 1989;142:549-553.
14. Bauer J, Ganter U, Geiger T, Jacobshagen U, Gilberto G. Regulation of interleukin 6 expression in cultured human blood monocytes and monocyte derived macrophages Blood. 1988;72:1134-1140.
15. Takemura R, Werb Z. Secretory products of macrophages and their physiological significance. Am J Physiol. 1984;246:C1-C9.
16. Seino Y, Ikeda U, Ikeda M, Yamamoto K, Misawa Y, Hasegawa T, Kano S, Shimada K. Interleukin 6 gene transcripts are expressed in human atherosclerotic lesions. Cytokine. 1994;6:87-91.
17. Raines EW, Rosenfeld ME, Ross R. The role of macrophages. In: Fuster V, Ross R, Topol EJ, eds. Atherosclerosis and Coronary Artery Disease. Philadelphia: Lippincott Raven; 1996:539-555.
18. Orlandi M, Bartolini G, Minghetti L, Luchetti S, Giulucci B, Chiricolo M, Tomasi V. Prostagladin and thromboxane biosynthesis in isolated platelet free monocytes, III: the induction of cyclooxygenase by colony stimulating factor-1. Prostagladins Leukot Essent Fatty Acids. 1989;36: 101-106.
19. Bhagat K, Vallance P. Inflammatory cytokines impair endothelial dependent dilatation in human veins in vivo. Circulation. 1997;96: 3042-3047.
20. Liuzzo G, Biasucci LM, Gallimore R, Grillo RL, Rebuzzi AG, Pepys MB, Maseri A. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med. 1994;331:417-420.
21. Biasucci LM, Vitelli A, Liuzzo D, Altamura S, Caliguri G, Monaco C, Rebuzzi AG, Ciliberto G, Maseri A. Elevated levels of interleukin-6 in unstable angina. Circulation. 1996;94:874-877.
22. Tashiro H, Simokawa H, Yamamoto K, Momomar M, Tada H, Taheshita A. Altered plasma levels of cytokines in patients with ischaemic heart disease. Coron Artery Dis. 1997;8:143-147.
23. Miyao Y, Yasue H, Ogawa H, Misumi I, Masuda T, Sakamoto T, Morita E. Elevated plasma interleukin-6 levels in patients with acute myocardial infarction. Am Heart J. 1993;126:1299-1304.
24. Tashiro H, Simokawa H, Yamamoto K, Nagano M, Momomar M, Muramatu K, Taheshita A. Monocyte-related cytokines in acute myocardial infarction. Am Heart J. 1995;130:446-452.
25. Parthenakis F, Simantirakis E, Zuridakis E, Kochiadakis G, Chrysostomakis S, Ikonomidis I, Vardas P. The incidence of ventricular arrhythmias during silent myocardial ischaemia in patients with coronary artery disease. Int J Cardiol. 57;1996:61-67.
26. Francus T. IL-1, IL-6 and PDGF mRNA expression in alveolar cells following stimulation with tobacco derived antigen. Cell Immunol. 1992; 145:156-174.
27. Seelentag WK, Mermod JJ, Montesano R, Vassalli P. Additive effects of interleukin 1 and tumor necrosis factor on the accumulation of the three granulocyte and macrophage colony stimulating factor mRNAs in human endothelial cells. EMBO J. 1991;6:2261-2265.
28. Oster W, Brach MA, Grass HJ, Mertelsmann R, Herrmann F. Interleukin-1 beta (IL-1 beta) expression in human blood mononuclear phagocytes is differentially regulated by granulocyte-macrophage colony stimulating factor (GM-CSF), M-CSF and IL-3 Blood. 1992;79: 1260-1265.
29. Castell JV, Andus T, Kunz D, Heinrich PC. Interleukin 6: the major regulator of acute phase protein in man and rat. Ann N Y Acad Sci. 1989;557:87-101.
30. Bataille R, Klein B. C-reactive protein levels as a direct indicator of Interleukin 6 levels in humans in vivo. Arthritis Rheum. 1992;35: 982-984.
31. Dinarello CA. Interleukin-1 and the pathogenesis of acute phase response. N Engl J Med. 1984;311:1413-1418.
32. Smith JD, Trogan E, Ginsberg M, Grigaux C, Tian J, Miyat M. Decreased atherosclerosis in mice deficient in both macrophage colony stimulating factor and apolipoprotein E. Proc Natl Acad Sci USA. 1995;92: 8264-8268.
33. Silverstein RL, Nachman RL. Thrombospondin binds to monocyte-macrophages and mediates platelet monocyte adhesion. J Clin Invest. 1987; 79:867-874.
34. Uhr MR, Schaufelberger HD, Hildebrand P, Berlinger C. [Thrombocytes express functional cytokine receptors in patients with Chron disease and ulcerative colitis]. Schweiz Med Wochenschr. 1995;125:970-974.
35. Yesner LM, Huh HY, Pearce SF, Silverstein RL. Regulation of monocyte CD36 and thrombospondin-1 expression by soluble mediators. Arterioscler Thromb Vasc Biol. 1996;16:1019-1025.
36. Lyberg T, Stanley ER, Prydz H. Colony stimulating factor-1 induces thromboplastin activity in murine macrophages and human monocytes. J Cell Physiol. 1987;132:367-370.
37. Wakenfield TW, Greenfield LJ, Rolfe MW, DeLucia A, Strieter RM, Abrams GD, Kunkel SL, Esmon CT, Wrobleski SK, Kadell AM. Inflammatory and procoagulant mediator interactions in an experimental baboon model of venous thrombosis. Thromb Haemost. 1993;69:164-172.
38. Lam JYT, Chesebro JH, Steele PM, Badimon L, Fuster V. Is vasospasm related to platelet deposition? Relationship in a porcine preparation of arterial injury in vivo. Circulation. 1987;75:243-248.
39. Kaski JC, Tousoulis D, Haider AW, Gavrielides S, Crea F, Maseri A. Reactivity of eccentric and concentric stenoses in patients with chronic stable angina. J Am Coll Cardiol. 1991;17:627-633.
40. Folts JD, Crowell EB, Rowe CG. Platelet aggregation in partially obstructed vessels and its elimination with aspirin. Circulation. 1976;54: 365-370.
41. Davies MJ. A macro and micro view of coronary vascular insult in ischaemic heart disease. Circulation. 1990;82(suppl II):II-38-II-46.
42. Deanfield JE, Maseri A, Selwyn AP, Ribeiro P, Cheirchia S, Krikler S, Morgan M. Myocardial ischaemia during daily life in patients with stable angina; its relation to symptoms and heart rate changes. Lancet. 1983;2: 753-758.
43. Kaufmann P, Vassali G, Ultzinger U, Hess OM. Coronary vasomotion during dynamic exercise. Influence of intravenous and intracoronary nicardipine. J Am Coll Cardiol. 1995;26:624-628.
44. Kukielka GL, Smith CW, Manning AM, Youker KA, Michael LH, Entman ML. Induction of Intreleukin-6 synthesis in the myocardium. Potential role in post-perfusion inflammatory injury. Circulation. 1995; 92:1866-1875.
45. Gaetano G, Cerletti C, Deiana E, Latini R. Pharmacology of platelet inhibition in humans: implications of the salicylate-aspirin interaction. Circulation. 1985;72:1185-1193.
46. Croock R, Grainger DJ, Irerson N, Salomone OA, Leatham EW, Kaski JC. Aspirin elevates circulating transforming growth factor-b in patients with chronic stable angina. Circulation. 1996;94:8(suppl):463. Abstract.